Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AZ.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AZ.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.260ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.260ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.260ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.260NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.456ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.456ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.456ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.456NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.4.16 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.16 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.16 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.16 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.70ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.70NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.42ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.42NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.428ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.428ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.428ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.428NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.374ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.374ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.374ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.374NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.63 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.63 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.63 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.63 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.377ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.377ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.377ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.377NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used